| Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro/in vivo evaluation SS Montoto, ML Sbaraglini, A Talevi, M Couyoupetrou, M Di Ianni, ... Colloids and Surfaces B: Biointerfaces 167, 73-81, 2018 | 97 | 2018 |
| Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats C Sedlinsky, MS Molinuevo, AM Cortizo, MJ Tolosa, JI Felice, ... European journal of pharmacology 668 (3), 477-485, 2011 | 77 | 2011 |
| Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties B Rodenak-Kladniew, SS Montoto, ML Sbaraglini, M Di Ianni, ME Ruiz, ... International journal of pharmaceutics 569, 118575, 2019 | 61 | 2019 |
| Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning LN Alberca, ML Sbaraglini, D Balcazar, L Fraccaroli, C Carrillo, ... Journal of computer-aided molecular design 30, 305-321, 2016 | 52 | 2016 |
| Neglected tropical protozoan diseases: drug repositioning as a rational option M Laura Sbaraglini, M Cristina Vanrell, C Leticia Bellera, G Benaim, ... Current topics in medicinal chemistry 16 (19), 2201-2222, 2016 | 45 | 2016 |
| Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease ML Sbaraglini, CL Bellera, L Fraccaroli, L Larocca, C Carrillo, A Talevi, ... International journal of antimicrobial agents 48 (1), 91-95, 2016 | 40 | 2016 |
| Saxagliptin affects long-bone microarchitecture and decreases the osteogenic potential of bone marrow stromal cells ML Sbaraglini, MS Molinuevo, C Sedlinsky, L Schurman, AD McCarthy European journal of pharmacology 727, 8-14, 2014 | 34 | 2014 |
| Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs GA Islan, ME Ruiz, JF Morales, ML Sbaraglini, AV Enrique, G Burton, ... Journal of Materials Chemistry B 5 (17), 3132-3144, 2017 | 30 | 2017 |
| Cascade ligand-and structure-based virtual screening to identify new trypanocidal compounds inhibiting putrescine uptake LN Alberca, ML Sbaraglini, JF Morales, R Dietrich, MD Ruiz, ... Frontiers in Cellular and Infection Microbiology 8, 173, 2018 | 23 | 2018 |
| In silico drug repositioning for Chagas disease CL Bellera, LN Alberca, ML Sbaraglini, A Talevi Current Medicinal Chemistry 27 (5), 662-675, 2020 | 21 | 2020 |
| A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors MA Llanos, ML Sbaraglini, ML Villalba, MD Ruiz, C Carrillo, C Alba Soto, ... Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1), 21-30, 2020 | 16 | 2020 |
| Hybrid compounds as anti-infective agents ML Sbaraglini, A Talevi Current Topics in Medicinal Chemistry 17 (9), 1080-1095, 2017 | 16 | 2017 |
| Trypanosoma cruzi Virulence Factors for the Diagnosis of Chagas’ Disease CY Chain, DE Pires Souto, ML Sbaraglini, CA Labriola, MA Daza Millone, ... ACS infectious diseases 5 (11), 1813-1819, 2019 | 14 | 2019 |
| Trypanosomatid-caused conditions: state of the art of therapeutics and potential applications of lipid-based nanocarriers G Muraca, IR Berti, ML Sbaraglini, WJ Fávaro, N Durán, GR Castro, ... Frontiers in chemistry 8, 601151, 2020 | 13 | 2020 |
| Knowledge-based drug repurposing: a rational approach towards the identification of novel medical applications of known drugs CL Bellera, ME Di Ianni, ML Sbaraglini, EA Castro, LE Bruno-Blanch, ... Frontiers in computational chemistry, 44-81, 2015 | 13 | 2015 |
| Modern approaches for the discovery of anti-infectious drugs for the treatment of neglected diseases CL Bellera, ML Sbaraglini, A Talevi Current Topics in Medicinal Chemistry 18 (5), 369-381, 2018 | 12 | 2018 |
| Structure-Based Virtual Screening Identifies Novobiocin, Montelukast, and Cinnarizine as TRPV1 Modulators with Anticonvulsant Activity In Vivo MA Llanos, N Enrique, ML Sbaraglini, FM Garofalo, A Talevi, L Gavernet, ... Journal of Chemical Information and Modeling 62 (12), 3008-3022, 2022 | 10 | 2022 |
| In silico modeling of FDA-approved drugs for discovery of therapies against neglected diseases: a drug repurposing approach CL Belllera, ML Sbaraglini, LN Alberca, JI Alice, A Talevi In silico drug design, 625-648, 2019 | 9 | 2019 |
| Parabens inhibit hNaV 1.2 channels A Enrique, P Martín, ML Sbaraglini, A Talevi, V Milesi Biomedicine & Pharmacotherapy 128, 110250, 2020 | 8 | 2020 |
| Articulación horizontal y vertical entre asignaturas universitarias: el Trayecto sobre Microscopía M Del Panno, ML García, L Kozubsky, S Morcelle, M Pardo, ML Sbaraglini, ... II Congreso Regional de Enseñanza de las Ciencias de la Naturaleza. Tandil …, 2017 | 8 | 2017 |
